Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Spinal posture, mobility, and balance in people with multiple sclerosis

Official title: Relationship Between Spinal Alignment, Spinal Mobility, and Balance in Patients With Multiple Sclerosis

Run by Ankara Yildirim Beyazıt University · NCT07648277 · Data updated 2026-11-12

This study will test how spinal posture and mobility relate to balance in adults with relapsing-remitting MS.

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment30 (estimated)
SponsorAnkara Yildirim Beyazıt University
Academic / other
Locations1 site (Ankara, Çubuk)
StatusRecruiting
StartedFebruary 1, 2026
Main results expectedJune 12, 2026
Study endsJune 30, 2026
Registry record updatedJune 15, 2026
Trial IDNCT07648277 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 with relapsing-remitting MS, EDSS 0.5–4.5, and adequate cognitive function (MMSE ≥24).

Probably not a fit

Individuals with higher disability (EDSS >4.5), other neurological conditions, recent corticosteroid use, or significant spasticity may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study looks at how spinal alignment and movement relate to balance performance in adults with relapsing-remitting multiple sclerosis. Participants aged 18–65 with an EDSS of 0.5–4.5 will be assessed for spinal posture, spinal mobility, and balance measures. The goal is to understand how posture and mobility patterns correlate with balance to inform future rehabilitation approaches.

Why it matters

Potential benefit: Findings could guide tailored rehabilitation to improve balance and functional independence in people with MS.

How similar studies have gone: Previous work has shown associations between posture, mobility, and balance in MS, but dedicated studies on spinal factors remain limited but promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of relapsing-remitting multiple sclerosis (RRMS)
* Aged between 18 and 65 years
* EDSS score between 0.5 and 4.5
* Standardized Mini-Mental State Examination score ≥24

Exclusion Criteria:

* Receipt of corticosteroid treatment within the previous 4 weeks
* Presence of any additional neurological disorder
* Spasticity defined as a Modified Ashworth Scale score ≥3
* History of surgical intervention involving the lower extremities, spine, or abdominal region

Where it's running

  • Ankara Yıldırım Beyazıt University
    Ankara, Çubuk, Turkey (Türkiye)
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.